Recently, higher RNA and/or protein TPPP3 levels have been found in glioblastoma, breast cancer, melanoma stem cells and endometrial cancer as well [20,21,22,23] where the higher TPPP3 expression levels are associated with poorer outcome and worse overall survival. Here, TPPP3 is linked to breast cancer.